UTAH VALLEY HOSPITAL
- Type
- Teaching hospital
- Where
- Provo, UT
- Medicare CCN
- 460001
- Received
- $979,795 in 84 records, 2020 ($21,404 general, $958,390 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2020 | General payment | 17 | $21,404 |
| 2020 | Research payment | 67 | $958,390 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Celgene Corporation | 2 | $803,284 | 2020 |
| Abbott Laboratories | 42 | $119,513 | 2020 |
| Boston Scientific Corporation | 10 | $14,375 | 2020 |
| ONY Biotech Inc. | 4 | $8,000 | 2020 |
| ACELL, INC. | 3 | $7,671 | 2020 |
| Stryker Corporation | 1 | $7,175 | 2020 |
| Edwards Lifesciences Corporation | 3 | $5,678 | 2020 |
| AstraZeneca Pharmaceuticals LP | 3 | $5,239 | 2020 |
| United Therapeutics Corporation | 4 | $3,799 | 2020 |
| Medical Device Business Services, Inc. | 2 | $1,500 | 2020 |
| GE HEALTHCARE | 1 | $1,000 | 2020 |
| KLS-Martin L.P. | 1 | $1,000 | 2020 |
| LEICA MICROSYSTEMS INC. | 5 | $545 | 2020 |
| Insulet Corporation | 1 | $500 | 2020 |
| Linvatec Corporation | 1 | $261 | 2020 |
| Cook Research Incorporated | 1 | $250 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 67 | $958,390 |
| Gift | 6 | $7,721 |
| Education | 3 | $7,671 |
| Space rental or facility fees (teaching hospital only) | 5 | $4,750 |
| Grant | 2 | $761 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 1 | $500 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Linvatec Corporation | $261 | Grant | In-kind items and services | MICROPOWER Device, ORTHOPEDIC SURGERY | 2020 | |
| 2020-12-31 | AstraZeneca Pharmaceuticals LP | $102 | Research payment | In-kind items and services | This is a randomized open label multi center global Phase III study to assess the efficacy and safety of durvalumab plus | 2020 | |
| 2020-12-21 | ONY Biotech Inc. | $1,500 | Research payment | Cash or cash equivalent | Infasurf Drug, Product | Aero-03 | 2020 |
| 2020-12-09 | Abbott Laboratories | $20,630 | Research payment | Cash or cash equivalent | TriClip Transcatheter Tricuspid Valve Repair System Device, Cardiac Arrhythmias and Heart Failure | Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal | 2020 |
| 2020-11-30 | Medical Device Business Services, Inc. | $750 | Research payment | Cash or cash equivalent | WaveCrest Vs. Watchman Transseptal LAA Closure to Reduce AF-Mediated Stroke 2 | 2020 | |
| 2020-11-20 | ONY Biotech Inc. | $1,500 | Research payment | Cash or cash equivalent | Infasurf Drug, Product | Aero-03 | 2020 |
| 2020-11-16 | Boston Scientific Corporation | $2,490 | Research payment | Cash or cash equivalent | ACUITY Device, TACHY | NAVIGATE X4 STUDY | 2020 |
| 2020-11-16 | Boston Scientific Corporation | $75 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-11-12 | Abbott Laboratories | $2,600 | Research payment | Cash or cash equivalent | TriClip Transcatheter Tricuspid Valve Repair System Device, Cardiac Arrhythmias and Heart Failure | Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal | 2020 |
| 2020-11-11 | Abbott Laboratories | $650 | Research payment | Cash or cash equivalent | MitraClip Device, Cardiac Arrhythmias and Heart Failure | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr | 2020 |
| 2020-11-10 | Stryker Corporation | $7,175 | Gift | In-kind items and services | SURG - SYSTEM 7 Device, SURGICAL | 2020 | |
| 2020-11-06 | ACELL, INC. | $2,557 | Education | Cash or cash equivalent | 2020 | ||
| 2020-11-04 | Abbott Laboratories | $1,575 | Research payment | Cash or cash equivalent | MitraClip Device, Cardiac Arrhythmias and Heart Failure | Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Ca | 2020 |
| 2020-11-04 | Insulet Corporation | $500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-10-30 | ACELL, INC. | $2,557 | Education | Cash or cash equivalent | 2020 | ||
| 2020-10-28 | Abbott Laboratories | $1,265 | Research payment | Cash or cash equivalent | Nanostim leadless pacemaker Device, Cardiac Arrhythmias and Heart Failure | Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker | 2020 |
| 2020-10-28 | ONY Biotech Inc. | $500 | Research payment | Cash or cash equivalent | Infasurf Drug, Product | Aero-03 | 2020 |
| 2020-10-23 | ACELL, INC. | $2,557 | Education | Cash or cash equivalent | 2020 | ||
| 2020-10-21 | Abbott Laboratories | $132 | Research payment | Cash or cash equivalent | MitraClip Device, Vascular | MitraClip EXPAND G4 Study | 2020 |
| 2020-10-19 | Medical Device Business Services, Inc. | $750 | Research payment | Cash or cash equivalent | WaveCrest Vs. Watchman Transseptal LAA Closure to Reduce AF-Mediated Stroke 2 | 2020 | |
| 2020-10-19 | Abbott Laboratories | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | FreeStyle Libre Device, Diabetes Care | 2020 | |
| 2020-10-01 | Abbott Laboratories | $3,500 | Research payment | Cash or cash equivalent | MitraClip Device, Vascular | Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Ca | 2020 |
| 2020-09-30 | Abbott Laboratories | $150 | Research payment | In-kind items and services | MitraClip Device, Vascular | Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Ca | 2020 |
| 2020-09-21 | Boston Scientific Corporation | $250 | Research payment | Cash or cash equivalent | ACUITY Device, TACHY | NAVIGATE X4 STUDY | 2020 |
| 2020-09-17 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | Dragonfly OPTIS optical coherence tomography (OCT) Device, Cardiac Arrhythmias and Heart Failure | Optical Coherence Tomography (OCT) Guided Coronary Stent Implantation Compared to Angiography: a Multicenter Randomized | 2020 |
| 2020-09-10 | Abbott Laboratories | $2,000 | Research payment | Cash or cash equivalent | TriClip Transcatheter Tricuspid Valve Repair System Device, Cardiac Arrhythmias and Heart Failure | Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal | 2020 |
| 2020-09-10 | Abbott Laboratories | $600 | Research payment | Cash or cash equivalent | TriClip Transcatheter Tricuspid Valve Repair System Device, Cardiac Arrhythmias and Heart Failure | Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal | 2020 |
| 2020-09-08 | Boston Scientific Corporation | $750 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-09-08 | Boston Scientific Corporation | $103 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-09-03 | Abbott Laboratories | $1,500 | Research payment | Cash or cash equivalent | Dragonfly OPTIS optical coherence tomography (OCT) Device, Cardiac Arrhythmias and Heart Failure | Optical Coherence Tomography (OCT) Guided Coronary Stent Implantation Compared to Angiography: a Multicenter Randomized | 2020 |
| 2020-09-03 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | MitraClip Device, Cardiac Arrhythmias and Heart Failure | A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of | 2020 |
| 2020-09-03 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | Nanostim leadless pacemaker Device, Cardiac Arrhythmias and Heart Failure | Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker | 2020 |
| 2020-09-03 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | Nanostim leadless pacemaker Device, Cardiac Arrhythmias and Heart Failure | Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker | 2020 |
| 2020-09-02 | GE HEALTHCARE | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Device, ULTRASOUND | 2020 | |
| 2020-08-31 | KLS-Martin L.P. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-08-27 | AstraZeneca Pharmaceuticals LP | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-08-26 | ONY Biotech Inc. | $4,500 | Research payment | Cash or cash equivalent | Infasurf Drug, Product | Aero-02 | 2020 |
| 2020-08-26 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | MitraClip Device, Vascular | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr | 2020 |
| 2020-08-12 | Abbott Laboratories | $1,415 | Research payment | Cash or cash equivalent | Nanostim leadless pacemaker Device, Cardiac Arrhythmias and Heart Failure | Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker | 2020 |
| 2020-08-05 | Abbott Laboratories | $1,040 | Research payment | Cash or cash equivalent | TriClip Transcatheter Tricuspid Valve Repair System Device, Cardiac Arrhythmias and Heart Failure | Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal | 2020 |
| 2020-07-23 | Abbott Laboratories | $10,000 | Research payment | Cash or cash equivalent | MitraClip Device, Cardiac Arrhythmias and Heart Failure | Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Ca | 2020 |
| 2020-07-22 | Abbott Laboratories | $1,705 | Research payment | Cash or cash equivalent | MitraClip Device, Cardiac Arrhythmias and Heart Failure | MitraClip EXPAND G4 Study | 2020 |
| 2020-07-22 | Abbott Laboratories | $251 | Research payment | Cash or cash equivalent | MitraClip Device, Cardiac Arrhythmias and Heart Failure | A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of | 2020 |
| 2020-07-16 | Edwards Lifesciences Corporation | $975 | Research payment | Cash or cash equivalent | Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves | Early-TAVR Trial #2016-07 | 2020 |
| 2020-07-09 | Edwards Lifesciences Corporation | $3,203 | Research payment | Cash or cash equivalent | Edwards PASCAL Transcatheter Valve Repair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study | 2020 | |
| 2020-06-17 | Abbott Laboratories | $18,335 | Research payment | Cash or cash equivalent | TriClip Transcatheter Tricuspid Valve Repair System Device, Cardiac Arrhythmias and Heart Failure | Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal | 2020 |
| 2020-06-15 | LEICA MICROSYSTEMS INC. | $204 | Gift | Cash or cash equivalent | N/A Device, CANCER DIAGNOSTICS | 2020 | |
| 2020-06-10 | United Therapeutics Corporation | $225 | Research payment | Cash or cash equivalent | ORENITRAM Drug, PAH | AN OPEN-LABEL EXTENSION STUDY OF ORAL TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION (PH) ASSOCIATED WITH HEART FA | 2020 |
| 2020-06-10 | United Therapeutics Corporation | $225 | Research payment | Cash or cash equivalent | ORENITRAM Drug, PAH | A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ORAL TREPROSTIN | 2020 |
| 2020-06-08 | LEICA MICROSYSTEMS INC. | $77 | Gift | Cash or cash equivalent | N/A Device, CANCER DIAGNOSTICS | 2020 | |
| 2020-06-03 | LEICA MICROSYSTEMS INC. | $195 | Gift | Cash or cash equivalent | N/A Device, CANCER DIAGNOSTICS | 2020 | |
| 2020-06-03 | LEICA MICROSYSTEMS INC. | $23 | Gift | Cash or cash equivalent | N/A Device, CANCER DIAGNOSTICS | 2020 | |
| 2020-05-20 | Abbott Laboratories | $4,851 | Research payment | Cash or cash equivalent | TriClip Transcatheter Tricuspid Valve Repair System Device, Cardiac Arrhythmias and Heart Failure | Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal | 2020 |
| 2020-05-19 | Cook Research Incorporated | $250 | Research payment | Cash or cash equivalent | Cook Medical Self-Expanding Stent Device, Peripheral Intervention | (11-010) Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstructi | 2020 |
| 2020-05-13 | Abbott Laboratories | $1,816 | Research payment | Cash or cash equivalent | Dragonfly OPTIS optical coherence tomography (OCT) Device, Cardiac Arrhythmias and Heart Failure | Optical Coherence Tomography (OCT) Guided Coronary Stent Implantation Compared to Angiography: a Multicenter Randomized | 2020 |
| 2020-05-06 | Abbott Laboratories | $1,587 | Research payment | Cash or cash equivalent | MitraClip Device, Cardiac Arrhythmias and Heart Failure | A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of | 2020 |
| 2020-04-29 | LEICA MICROSYSTEMS INC. | $43 | Gift | Cash or cash equivalent | N/A Device, CANCER DIAGNOSTICS | 2020 | |
| 2020-04-22 | Abbott Laboratories | $5,787 | Research payment | Cash or cash equivalent | MitraClip Device, Cardiac Arrhythmias and Heart Failure | MitraClip EXPAND G4 Study | 2020 |
| 2020-04-21 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | MitraClip Device, Vascular | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr | 2020 |
| 2020-04-21 | Abbott Laboratories | $350 | Research payment | Cash or cash equivalent | MitraClip Device, Vascular | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr | 2020 |
| 2020-04-20 | Boston Scientific Corporation | $7,650 | Research payment | Cash or cash equivalent | ACUITY Device, TACHY | NAVIGATE X4 STUDY | 2020 |
| 2020-04-15 | Abbott Laboratories | $2,196 | Research payment | Cash or cash equivalent | Nanostim leadless pacemaker Device, Cardiac Arrhythmias and Heart Failure | Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker | 2020 |
| 2020-04-15 | Boston Scientific Corporation | $500 | Grant | Cash or cash equivalent | GENERAL - STRUCTURAL HEART Device, STRUCTURAL HEART | 2020 | |
| 2020-04-06 | Boston Scientific Corporation | $236 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-04-02 | Abbott Laboratories | $250 | Research payment | Cash or cash equivalent | Dragonfly OPTIS optical coherence tomography (OCT) Device, Cardiac Arrhythmias and Heart Failure | Optical Coherence Tomography (OCT) Guided Coronary Stent Implantation Compared to Angiography: a Multicenter Randomized | 2020 |
| 2020-03-31 | Abbott Laboratories | $150 | Research payment | In-kind items and services | TriClip Transcatheter Tricuspid Valve Repair System Device, Vascular | Trial to Evaluate Treatment with Abbott Transcatheter Clip Repair System in Patients with Moderate or Greater Tricuspid | 2020 |
| 2020-03-31 | Abbott Laboratories | $90 | Research payment | In-kind items and services | MitraClip Device, Vascular | MitraClip EXPAND G4 Study | 2020 |
| 2020-03-31 | Abbott Laboratories | $40 | Research payment | In-kind items and services | MitraClip Device, Vascular | MitraClip EXPAND G4 Study | 2020 |
| 2020-03-18 | Abbott Laboratories | $10,900 | Research payment | Cash or cash equivalent | MitraClip Device, Vascular | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional MR ( | 2020 |
| 2020-03-12 | Abbott Laboratories | $1,250 | Research payment | Cash or cash equivalent | TriClip Transcatheter Tricuspid Valve Repair System Device, Cardiac Arrhythmias and Heart Failure | Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal | 2020 |
| 2020-02-26 | Edwards Lifesciences Corporation | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves | 2020 | |
| 2020-02-18 | Boston Scientific Corporation | $2,070 | Research payment | Cash or cash equivalent | ACUITY Device, TACHY | NAVIGATE X4 STUDY | 2020 |
| 2020-02-18 | Boston Scientific Corporation | $250 | Research payment | Cash or cash equivalent | ACUITY Device, TACHY | NAVIGATE X4 STUDY | 2020 |
| 2020-02-12 | United Therapeutics Corporation | $3,000 | Research payment | Cash or cash equivalent | An open-label extension study of APD811-003 in Patients with Pulmonary Arterial Hypertension | 2020 | |
| 2020-02-12 | Abbott Laboratories | $1,501 | Research payment | Cash or cash equivalent | Dragonfly OPTIS optical coherence tomography (OCT) Device, Cardiac Arrhythmias and Heart Failure | Optical Coherence Tomography (OCT) Guided Coronary Stent Implantation Compared to Angiography: a Multicenter Randomized | 2020 |
| 2020-02-12 | Abbott Laboratories | $752 | Research payment | Cash or cash equivalent | Xience V Coronary Stent System Device, Cardiac Arrhythmias and Heart Failure | ILUMIEN IV: OPTIMAL PCI | 2020 |
| 2020-02-12 | United Therapeutics Corporation | $349 | Research payment | Cash or cash equivalent | An open-label extension study of APD811-003 in Patients with Pulmonary Arterial Hypertension | 2020 | |
| 2020-02-06 | Abbott Laboratories | $10,000 | Research payment | Cash or cash equivalent | MitraClip Device, Cardiac Arrhythmias and Heart Failure | MitraClip EXPAND G4 Study | 2020 |
| 2020-01-29 | Abbott Laboratories | $1,740 | Research payment | Cash or cash equivalent | MitraClip Device, Cardiac Arrhythmias and Heart Failure | A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of | 2020 |
| 2020-01-28 | Celgene Corporation | $434,337 | Research payment | Cash or cash equivalent | A Phase 2 study of JCAR017 as Second-Line Therapy in Adult Patients with Aggressive B-cell NHL | 2020 | |
| 2020-01-22 | Abbott Laboratories | $3,205 | Research payment | Cash or cash equivalent | Nanostim leadless pacemaker Device, Cardiac Arrhythmias and Heart Failure | Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker | 2020 |
| 2020-01-16 | Abbott Laboratories | $700 | Research payment | Cash or cash equivalent | MitraClip Device, Vascular | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr | 2020 |
| 2020-01-14 | Celgene Corporation | $368,946 | Research payment | Cash or cash equivalent | A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) | 2020 | |
| 2020-01-07 | AstraZeneca Pharmaceuticals LP | $4,386 | Research payment | Cash or cash equivalent | This is a randomized open label multi center global Phase III study to assess the efficacy and safety of durvalumab plus | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Provo, UT, county Utah County, UT, state Utah; placed by its city name.
| Measure | Place (city or town) Provo, UT | County Utah County, UT | State Utah |
|---|---|---|---|
| Population B01003 | 114,766 | 705,400 | 3,392,331 |
| Population, 2020 census P1 | 115,162 | 659,399 | 3,271,616 |
| Median age B01002 | 23.6 | 25.8 | 32.0 |
| Under 18 B01001 | 18.7% | 31.6% | 27.8% |
| 65 and over B01001 | 6.7% | 7.9% | 11.9% |
| Households B11001 | 34,022 | 203,018 | 1,124,822 |
| Foreign born B05002 | 12.5% | 8.2% | 8.9% |
| Median household income B19013 | $64,171 | $100,671 | $95,166 |
| Median family income B19113 | $73,450 | $110,986 | $109,675 |
| Per capita income B19301 | $27,822 | $37,082 | $40,873 |
| Poverty rate B17001 | 23.0% | 8.7% | 8.5% |
| Unemployment rate B23025 | 5.1% | 3.8% | 3.6% |
| Civilian labor force B23025 | 69,670 | 363,771 | 1,778,106 |
| Mean commute (minutes) B08013 | 18.4 | 22.6 | 22.1 |
| Bachelor's degree or higher B15003 | 45.2% | 44.4% | 37.7% |
| Housing units B25001 | 35,944 | 211,066 | 1,223,468 |
| Owner-occupied B25003 | 39.4% | 68.3% | 70.2% |
| Renters B25003 | 60.6% | 31.7% | 29.8% |
| Median home value B25077 | $467,200 | $538,700 | $489,400 |
| Median gross rent B25064 | $1,193 | $1,541 | $1,496 |
| White, not Hispanic B03002 | 70.8% | 77.6% | 74.7% |
| Black B03002 | 1.1% | 0.7% | 1.1% |
| Hispanic or Latino B03002 | 19.2% | 14.5% | 15.9% |
| Asian B03002 | 2.2% | 1.5% | 2.4% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.6% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Provo, UT.
Comments